派思股份(603318.SH)正籌劃定增 募資擬用於收購銀川中油精誠燃氣100%股權及子長華成天然氣65%股權
格隆匯11月13日丨派思股份(603318.SH)公佈,公司正在籌劃非公開發行股票事項,此次非公開發行股票募集資金擬用於收購上海華彗曙智能源發展有限公司持有的銀川中油精誠燃氣有限公司100%股權、子長華成天然氣有限公司65%股權,及償還銀行貸款和補充流動資金。
此次收購以非公開發行股票取得中國證監會核准為前置條件,若未成功實施非公開發行,則此次收購無法實施。
此次非公開發行股票的數量不超過此次發行前公司總股本的20%,即不超過80,432,455股,並以中國證監會核準的發行數量為準。此次發行不會導致公司控制權發生變化。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.